Eyenovia Inc (EYEN)
1.01
+0.07
(+7.74%)
USD |
NASDAQ |
May 03, 16:00
1.02
+0.01
(+0.99%)
After-Hours: 20:00
Eyenovia Cash from Investing (TTM): -3.970M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -3.970M |
September 30, 2023 | -4.137M |
June 30, 2023 | -2.597M |
March 31, 2023 | -1.505M |
December 31, 2022 | -0.8747M |
September 30, 2022 | -1.016M |
June 30, 2022 | -1.370M |
March 31, 2022 | -1.482M |
December 31, 2021 | -1.618M |
September 30, 2021 | -1.224M |
June 30, 2021 | -0.7768M |
March 31, 2021 | -0.5116M |
December 31, 2020 | -0.2613M |
Date | Value |
---|---|
September 30, 2020 | -0.3252M |
June 30, 2020 | -0.2989M |
March 31, 2020 | -0.2606M |
December 31, 2019 | -0.1666M |
September 30, 2019 | -0.0714M |
June 30, 2019 | -0.0279M |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | -0.0102M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-4.137M
Minimum
Sep 2023
-0.0279M
Maximum
Jun 2019
-1.184M
Average
-0.8747M
Median
Dec 2022
Cash from Investing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -0.019M |
Alpine Immune Sciences Inc | -55.56M |
Lantern Pharma Inc | -0.9302M |
Oragenics Inc | -0.9363M |
MAIA Biotechnology Inc | -- |